{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T03:08:45Z","timestamp":1786763325770,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["2011\/01\/B\/NZ4\/04909"],"award-info":[{"award-number":["2011\/01\/B\/NZ4\/04909"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Institute of Psychiatry and Neurology","award":["501-003-12043"],"award-info":[{"award-number":["501-003-12043"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.neuroscience.2012.12.052","type":"journal-article","created":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T20:01:46Z","timestamp":1357675306000},"page":"135-145","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["The kynurenine pathway: A missing piece in the puzzle of valproate action?"],"prefix":"10.1016","volume":"234","author":[{"given":"P.","family":"Maciejak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Szyndler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Turzy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sobolewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ko\u0142osowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"P\u0142a\u017anik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neuroscience.2012.12.052_b0005","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1471-4159.1992.tb11001.x","article-title":"Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain: an in vivo microdialysis study","volume":"59","author":"Biggs","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0010","doi-asserted-by":"crossref","first-page":"479364","DOI":"10.1155\/2010\/479364","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","volume":"2010","author":"Chateauvieux","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mcn.2004.12.003","article-title":"How can the mood stabilizer VPA limit both mania and depression?","volume":"29","author":"Cheng","year":"2005","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0020","doi-asserted-by":"crossref","unstructured":"Chronicle E, Mulleners W (2004) Anticonvulsant drugs for migraine prophylaxis. Cochrane Database Syst Rev CD003226.","DOI":"10.1002\/14651858.CD003226.pub2"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0025","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/01.STR.0000217303.22856.38","article-title":"Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia","volume":"37","author":"Costa","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0030","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/242198a0","article-title":"The effect of fatty acids on the binding of tryptophan to plasma protein","volume":"242","author":"Curzon","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0035","doi-asserted-by":"crossref","first-page":"1579S","DOI":"10.1093\/jn\/137.6.1579S","article-title":"Aromatic amino acid metabolism during liver failure","volume":"137","author":"Dejong","year":"2007","journal-title":"J Nutr"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0026-895X(25)14614-2","article-title":"Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone","volume":"21","author":"Fehske","year":"1981","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0045","doi-asserted-by":"crossref","DOI":"10.1093\/jn\/135.6.1539S","article-title":"Branched-chain amino acids and brain function","volume":"135","author":"Fernstrom","year":"2005","journal-title":"J Nutr"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0050","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/j.1552-4604.1980.tb02544.x","article-title":"Albumin-binding interactions of sodium valproate","volume":"20","author":"Fleitman","year":"1980","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0304-3940(84)90050-8","article-title":"Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid","volume":"48","author":"Foster","year":"1984","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0060","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","article-title":"Blood\u2013brain barrier transport of kynurenines: implications for brain synthesis and metabolism","volume":"56","author":"Fukui","year":"1991","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0378-4347(95)00341-X","article-title":"Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection","volume":"675","author":"Herve","year":"1996","journal-title":"J Chromatogr B Biomed Appl"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-8993(94)91601-2","article-title":"Kynurenate is neuroprotective following experimental brain injury in the rat","volume":"655","author":"Hicks","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0028-3908(79)90147-3","article-title":"Effect of valproic and acid on serotonin metabolism","volume":"18","author":"Hwang","year":"1979","journal-title":"Neuropharmacology"},{"issue":"8146","key":"10.1016\/j.neuroscience.2012.12.052_b0080","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(79)92119-6","article-title":"Hyperammonaemia plasma amino acid imbalance, and blood-brain amino acid transport: a unified theory of portasystemic encephalopathy","volume":"13","author":"James","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0085","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/08830738050200070801","article-title":"Protective effects of valproic acid against hypoxic-ischemic brain injury in neonatal rats","volume":"20","author":"Kabakus","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0090","first-page":"741","article-title":"Deficit of endogenous kynurenic acid in the frontal cortex of rats with a genetic form of absence epilepsy","volume":"55","author":"Kami\u0144ski","year":"2003","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0304-3940(90)90416-7","article-title":"Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons","volume":"116","author":"Kelly","year":"1990","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-1-4419-8969-7_10","article-title":"Kynurenines in neurodegenerative disorders: therapeutic consideration","volume":"541","author":"Klivenyi","year":"2004","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0105","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1248\/bpb.25.695","article-title":"Practical aspects of the ligand-binding and enzymatic properties of human serum albumin","volume":"25","author":"Kragh-Hansen","year":"2002","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0110","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0006-2952(02)01074-2","article-title":"Predicting plasma protein binding of drugs: a new approach","volume":"1","author":"Kratochwil","year":"2002","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.neuroscience.2012.12.052_b0115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pbb.2010.12.008","article-title":"Evidence for a key role of the peripheral kynurenine pathway in the modulation of anxiety- and depression-like behaviours in mice: focus on individual differences","volume":"98","author":"Laugeray","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0120","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1523\/JNEUROSCI.0096-06.2006","article-title":"Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity","volume":"26","author":"Leng","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0125","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35 year of clinical use for the treatment of epilepsy","volume":"16","author":"L\u00f6scher","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(84)90509-9","article-title":"Valproic acid increases gamma-aminobutyric acid in CSF of epileptic children","volume":"2","author":"L\u00f6scher","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0135","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.brainres.2007.10.010","article-title":"The opposite role of hippocampal mGluR1 in fear conditioning in kindled and non-kindled rats","volume":"1187","author":"Maciejak","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0140","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S1734-1140(11)70723-X","article-title":"Kynurenic acid: a new effector of valproate action?","volume":"63","author":"Maciejak","year":"2011","journal-title":"Pharmacol Rep"},{"issue":"2","key":"10.1016\/j.neuroscience.2012.12.052_b0145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0165-1781(97)00046-2","article-title":"Effects of subchronic treatment with valproate on L-5-HTP-induced cortisol responses in mania: evidence for increased central serotonergic neurotransmission","volume":"71","author":"Maes","year":"1997","journal-title":"Psychiatry Res"},{"issue":"3","key":"10.1016\/j.neuroscience.2012.12.052_b0150","first-page":"264","article-title":"Somatization, but not depression, is characterized by disorders in the tryptophan catabolite (TRYCAT) pathway, indicating increased indoleamine 2,3-dioxygenase and lowered kynurenine aminotransferase activity","volume":"32","author":"Maes","year":"2011","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0155","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1124\/jpet.105.097402","article-title":"Role of site-specific binding to plasma albumin in drug availability to brain","volume":"317","author":"Mandula","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0160","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1172\/JCI104191","article-title":"Studies of unbound amino acid distributions in plasma, erythrocytes, leukocytes and urine of normal human subjects","volume":"39","author":"Mcmenamy","year":"1960","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0165","first-page":"435","article-title":"Propri\u00e9t\u00e9s pharmacodynamiques de l\u2019acide n-dipropylac\u00e9tique","volume":"18","author":"Meunier","year":"1963","journal-title":"Th\u00e9rapie"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0170","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/1874467210902010095","article-title":"Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection","volume":"2","author":"Monti","year":"2009","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0175","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","article-title":"Kynurenine pathway in major depression: evidence of impaired neuroprotection","volume":"98","author":"Myint","year":"2007","journal-title":"J Affect Disord"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0180","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0185","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of Valproate: a summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0285","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.brainresbull.2007.12.001","article-title":"The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of L-kynurenine to kynurenic acid: an in vitro study","volume":"76","author":"Rozsa","year":"2008","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0200","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-3940(97)13472-3","article-title":"Pretreatment with L-kynurenine, the precursor to the excitatory amino acid antagonist kynurenic acid, suppresses epileptiform activity in combined entorhinal\/hippocampal slices","volume":"224","author":"Scharfman","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.034439","article-title":"Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities","volume":"303","author":"Schwarcz","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0210","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.nbd.2007.02.006","article-title":"Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation","volume":"26","author":"Sinn","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0215","first-page":"767","article-title":"Binding of drugs to human serum albumin: I. The specificity of three binding sites as studied with albumin immobilized in microparticles","volume":"16","author":"Sjoholm","year":"1979","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0220","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0304-3940(88)90414-4","article-title":"Comparison of kynurenic acid and 2-APV suppression of epileptiform activity in rat hippocampal slices","volume":"84","author":"Stone","year":"1988","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0225","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1742-4658.2012.08487.x","article-title":"Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection","volume":"279","author":"Stone","year":"2012","journal-title":"FEBS J"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0230","first-page":"824","article-title":"The characterization of two specific drug binding sites on human serum albumin","volume":"11","author":"Sudlow","year":"1975","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0235","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/jnnp.43.8.739","article-title":"Effect of dialysis on plasma and CSF tryptophan and CSF 5-hydroxyindoleacetic acid in advanced renal disease","volume":"43","author":"Sullivan","year":"1980","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0240","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00702-011-0700-z","article-title":"The effects of electrical hippocampal kindling of seizures on amino acids and kynurenic acid concentrations in brain structures","volume":"119","author":"Szyndler","year":"2012","journal-title":"J Neural Transm"},{"issue":"5","key":"10.1016\/j.neuroscience.2012.12.052_b0245","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/j.1471-4159.1989.tb09218.x","article-title":"Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine","volume":"52","author":"Turski","year":"1989","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0250","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2009.02.326","article-title":"The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection","volume":"283","author":"Vamos","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0255","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1528-1157.1986.tb03525.x","article-title":"Valproate reduces excitability by blockage of sodium and potassium conductance","volume":"27","author":"VanDongen","year":"1986","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0260","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0361-9230(92)90184-Y","article-title":"Kynurenine and probenecid inhibit pentylenetetrazol- and NMDA-induced seizures and increase kynurenic acid concentrations in the brain","volume":"28","author":"Vecsei","year":"1992","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0265","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0014-2999(91)90681-F","article-title":"The effect of valproic acid on 5-hydroxytryptamine and 5-hydroxyindoleacetic acid concentration in hippocampal dialysates in vivo","volume":"200","author":"Whitton","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0270","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/j.1460-9568.1992.tb00152.x","article-title":"Kynurenic acid in the quinolinate-lesioned rat hippocampus: studies in vitro and in vivo","volume":"4","author":"Wu","year":"1992","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0275","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00702-009-0263-4","article-title":"Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies","volume":"116","author":"Zadori","year":"2009","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuroscience.2012.12.052_b0280","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0006-8993(91)90078-A","article-title":"Valproate suppresses N-methyl-d-aspartate-evoked, transient depolarizations in the rat neocortex in vitro","volume":"544","author":"Zeise","year":"1991","journal-title":"Brain Res"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452213000079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452213000079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T16:30:05Z","timestamp":1745944205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452213000079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":55,"alternative-id":["S0306452213000079"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2012.12.052","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}